The global preventive healthcare technologies and services market is expected to reach $441.5 billion by 2027 according to a recent report.
The Business Research Company’s “Preventive Healthcare Technologies And Services Global Market Report 2023” predicts that the preventive healthcare technologies and services market size is set to grow to a value of $441.5 billion in 2027 at a compound annual growth rate (CAGR) of 15.1%. The market is being driven by the increasing prevalence of chronic diseases, the rising aging population, and the growing awareness of the importance of preventive healthcare.
Key takeaways from the report:
- The global preventive healthcare technologies and services market is expected to grow at a CAGR of 15.1% from 2023 to 2027.
- The market is being driven by the increasing prevalence of chronic diseases, the rising aging population, and the growing awareness of the importance of preventive healthcare.
- Early detection and screening technologies are the largest segment of the market, accounting for 42.5% of the market in 2022.
- Chronic disease management is the largest application segment of the market, accounting for 44.2% of the market in 2022.
- Hospitals are the largest end-user segment of the market, accounting for 45.9% of the market in 2022.
- North America is the largest market, accounting for 38.3% of the market in 2022.
- IBM, Philips, GE Healthcare, and Johnson & Johnson are the key players in the market.
The report segments the market by type, application, end-user, and region. By type, the market is segmented into early detection and screening technologies, personalized medicine, and other preventive healthcare technologies and services. Early detection and screening technologies are the largest segment, accounting for 42.5% of the market in 2022. This is due to the increasing demand for early diagnosis of diseases such as cancer and cardiovascular diseases.
By application, the market is segmented into chronic disease management, wellness programs, and others. Chronic disease management is the largest segment, accounting for 44.2% of the market in 2022. This is due to the rising prevalence of chronic diseases such as diabetes, hypertension, and obesity.
By end-user, the market is segmented into hospitals, clinics, and home healthcare. Hospitals are the largest end-user segment, accounting for 45.9% of the market in 2022. This is due to the increasing number of hospitals adopting preventive healthcare technologies and services to improve patient outcomes.
By region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is the largest market, accounting for 38.3% of the market in 2022. This is due to the high prevalence of chronic diseases and the early adoption of preventive healthcare technologies and services in the region.
The report also provides a competitive analysis of the market, including the key players such as IBM, Philips, GE Healthcare, and Johnson & Johnson. These companies are investing in research and development to develop innovative preventive healthcare technologies and services.
The report concludes by providing a forecast of the market from 2023 to 2027. The market is expected to grow at a CAGR of 15.1% during the forecast period.
Photo credit: Tara Winstead / Pexels